Biderra
Pharma and laboratory590518-2026

Belgium – Pharmaceutical products – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

Open official TED notice Similar notices

Buyer country

Belgium

Publication date

Not specified

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
71%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33600000

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Bélgica – Productos farmacéuticos – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

Dutch

België – Farmaceutische producten – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

Polish

Belgia – Produkty farmaceutyczne – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

French

Belgique – Produits pharmaceutiques – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

German

Belgien – Arzneimittel – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

Italian

Belgio – Prodotti farmaceutici – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

English

Belgium – Pharmaceutical products – Supply of point of care diagnostic to respond to the Ebola Bundibugyo outbreak

What Biderra adds

For notice 590518-2026, Biderra has normalized the contracting authority country as Belgium, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.